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Abstract
Congenital	heart	disease	has	an	overall	 incidence	of	8-10/1000	live	births	and	is	similar	across	the	globe.	The	incidence	may	be	
higher in countries where consanguinity is high, suggesting an autosomal recessive gene as a risk factor. Advances in surgical 
expertise, have improved outcome of simple and complex heart diseases. Early diagnosis and referral to centers caring for such 
babies is an important contributory factor to a better outcome.
This	review	focuses	on	early	diagnosis	of	congenital	heart	disease	in	neonates	and	children	by	Health	Care	Physicians	(General	and	
Family Physicians) and Pediatricians. Careful neonatal and pediatric cardiovascular examination, screening pulse oximetry on all 
newborns before hospital discharge and an early post natal follow up is important to diagnose CHD. 
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INTRODUCTION
Congenital heart disease (CHD) is one of the most 
serious	birth	 defects	 occurring	 in	 8-10/1000	 live	 births	
and	is	responsible	for	3%	of	all	infant	deaths	[1].	Forty-six	
percent of deaths are due to congenital malformations 
and congenital heart disease. The actual incidence 





Given	 the	 incidence	of	CHD	and	a	birth	 rate	of	2.16%	
and	a	population	of	208	million	(Pakistan	demographics’	
profile,	 2019)	 [5],	 around	65,000	babies	 are	 born	with	
congenital heart disease every year in Pakistan. Around 
5%	of	 these	will	 present	 as	a	neonatal	 cardiovascular	
emergency.
Advances in medical and surgical management of 
CHD have resulted in improved outcome in diseases 
which previously carried high mortality. Pivotal to such 
outcomes is early diagnosis and timely referral to centers 
offering	this	expertise	[6].
ETIOLOGY AND RISK FACTORS FOR CHD
The etiology of CHD is hypothesized to be multifactorial, 
which includes factors like genetic predisposition, 
environmental	insults	and	several	unidentified	factors.
Risk factors for the development of CHD include 
maternal co-morbidities like hypertension, diabetes 
mellitus, infections like rubella, use of anti-epileptic 
drugs,	alcohol,	antibiotics	during	pregnancy	[3,	7],	oral	
contraceptives, exposure to radiation and assisted 
reproductive technology. Family history of CHD is 
an independent risk factor, particularly if one of the 
parents	 has	 CHD	 (20-25%	 recurrence	 in	 offspring).	
Children with syndromes are also at a higher risk of 
having CHD as are those with associations, namely 
VACTERL	 (vertebral	 defects,	 anal	 atresia,	 cardiac	
defects,	 tracheoesophageal	 fistula,	 renal	 anomalies	
and	limb	abnormalities)	and	CHARGE	(coloboma,	heart	
defects, atresia choanae, growth retardation, genital 
abnormalities, and ear abnormalities).
The incidence on CHD may be higher in inbred 
populations	 like	Pakistan	 [3,	 7-10].	Consanguinity	 has	
been	 identified	 as	 a	 risk	 factor	 in	 the	 Middle	 Eastern	
countries	 with	 an	 increase	 in	 incidence	 by	 1.8	 times	
in consanguineous parents as compared to unrelated 
parents	[8].	One	study	from	India	was	unable	to	identify	
autosomal recessive inheritance in a heterogeneous 
cohort	of	children	with	CHD	[9].
TYPES OF CONGENITAL HEART DISEASES
CHD are categorized as acyanotic CHDs (with shunts 
and with obstructions) and cyanotic CHDs. Table 1 lists 
these defects. The most common acyanotic CHD is 
the ventricular septal defect, which has an incidence of 
4/1000	 live	births,	 followed	by	atrial	 septal	 defect	with	
an	 incidence	of	 2/1000	 live	births	 [1].	Among	cyanotic	
CHD, tetralogy of Fallot is the most common, having an 
incidence	of	0.5/1000	live	births.




  Atrial septal defect
  Patent ductus arteriosus
  Atrioventricular septal defect
	 Obstructive
  Aortic stenosis
  Pulmonary stenosis 
  Coarctation of aorta 
  Interrupted aortic arch
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  Tetralogy of Fallot 
  Transposition of great arteries 
  Total anomalous pulmonary venous connection 
  Truncus arteriosus 
  Tricuspid valve anomalies: Ebstein anomaly
 Complex heart diseases: 
  Hypoplastic left heart syndrome 
  Univentricular heart 
  Heterotaxy syndromes 
CRITICAL CONGENITAL HEART 
DISEASE (CCHD)
CCHD	 is	 defined	 by	 the	 Task	 Force	 on	 Screening	
Critical	 Congenital	 Heart	 Disease	 [11]	 as	 congenital	




Table 2: Critical congenital heart diseases.
d-Transposition of great arteries
Pulmonary atresia with or without septal defect
Critical pulmonary stenosis with or without septal defect
Tricuspid atresia with critical pulmonary stenosis
Hypoplastic left heart syndrome 
Truncus arteriosus
Obstructed	TAPVR




Even in the developed resourceful countries with 
active screening programs, Chang et al.	 [4]	 reported	
30 neonates dying each year of missed CCHD at birth 
in California. They found the median age of demise 
to be less than 2 weeks, concluding that these were 
preventable by careful cardiovascular examination for 
left	sided	obstructive	lesions	in	the	Pediatricians	office	in	
an	early	post	natal	visit	at	3-5	days	of	life.
CLUES TO DIAGNOSIS OF CONGENITAL 
HEART DISEASE
Neonates with CHD have vague symptoms of poor 
feeding, lethargy or tachypnea. These symptoms are 
also seen in many other serious and perhaps more 
common neonatal diseases like sepsis, pneumonia, and 
metabolic disorders.
Children with CHD may have minimal or obvious 
symptoms.	Lesions	with	excessive	pulmonary	blood	flow	
present with tachypnea which becomes pronounced 
during milk feeding or exercise. Easy fatigability and 
excessive sweating are features of left to right shunt of 
significant	 magnitude.	 Recurrent	 respiratory	 infections	
may be a clue to CHD. 
Peripheral cyanosis or acrocyanosis is more common 
and is a physiological response to certain conditions like 
exposure to cold temperatures, fright, or nervousness. 
This is due to vasoconstriction of skin blood vessels and 
should not be confused with central cyanosis. Central 
cyanosis due to CHD is because of arterial desaturation, 
and is present at all times, not intermittently. It is initially 
seen on the inner surface of lips and tongue. Naked eye 
may not appreciate mild cyanosis. Moderate degree of 
cyanosis	may	be	noted	on	finger	and	toe	nails.	
Routine examination of newborn babies detects less 
than half of them with CHD because the majority of 
them	are	asymptomatic	and	signs	may	be	subtle	 [12].	
A normal examination does not rule out CHD. In fact 
severe CHD may not have any murmur. In particular, 
left heart obstructive lesions like coarctation of aorta and 
interrupted	aortic	arch	can	easily	be	overlooked.	On	the	
other hand, a normal newborn can have physiological 
murmur of a patent ductus arteriosus, pulmonary artery 
branch hypoplasia or tricuspid regurgitation. Therefore, 
only a high index of suspicion will pick up this group of 
diseases. Considering that at least half of the newborns 
with murmur may have a structural heart disease, they 
should	 be	 referred	 for	 echocardiogram	 [13].	 Older	
children will have signs of abnormal peripheral pulses 
(high or low volume), hyperdynamic precordium, 
abnormal heart sounds and murmurs. Flaring of alai 
nasi, intercostal and subcostal chest retractions should 
alert a physician to an underlying CHD.
Hypercyanotic spell is a complication of cyanotic heart 
diseases	 with	 reduced	 pulmonary	 blood	 flow	 and	 is	
certainly not an early symptom. Similarly, headache, 
vomiting, fever, seizures and stroke indicate cerebral 
complications. Presence of a systemic disease or a 
syndrome should alert a physician to an associated 
cardiac anomaly. Midline defects may also have CHD 
[14].
Abnormal	cardiac	silhouette	on	a	chest	X-ray	done	for	




made during birth hospitalization and late detection 
is	 diagnosis	 after	 being	 discharged	 from	 hospital	 [6].	
In the developed countries, pulse oximetry screening 
(POS)	 is	 routinely	 done	 in	 all	 newborn	 babies	 before	
being discharged after birth. Critical congenital heart 
disease	can	be	picked	up	by	 this	simple	 test.	Oxygen	
saturation by pulse oximetry can be measured at a post 
ductal location (distal to the insertion of patent ductus 
arteriosus which is mostly the lower limb) or combination 
of pre ductal (which is proximal to the insertion of patent 
ductus arteriosus, which is usually the upper limb) and 
post	ductal	and	the	acceptable	normal	value	is	95%	[15].	
In the West, screening programs vary between centers. 
The American Academy of Pediatrics and the American 
Heart	Association	recommend	screening	newborns	at	24	
to	48	hours	of	life	with	use	of	both	pre-	and	post-ductal	
measurements	 [16].	An	 oxygen	 saturation	 in	 the	 right	
hand	and	 foot	0f>	95%	makes	 the	screening	negative	
[13].	 POS	 may	 not	 detect	 acyanotic	 heart	 diseases	
like ventricular septal defect, atrial septal defect or a 




and duct dependent acyanotic CCHD which may need 
urgent intervention.
In	 a	 study	 from	 Pakistan,	 the	 sensitivity,	 specificity,	
positive predictive value, and negative predictive value 




Several studies have reported improved diagnostic 
value of a combined careful clinical examination and 
POS	[18]	with	an	improvement	in	sensitivity	to	51%	[6].	
Yet another study showed the sensitivity of the combined 
method	of	evaluation	by	clinical	examination	and	POS	to	
be	77%,	and	 for	POS	alone	 it	was	31%,	and	46%	 for	
clinical	examination	alone	[19].
Diagnostic accuracy of clinical examination alone is very 
subjective, based on geographical region and related 
to	 approach	 to	 diagnosing	 CHD	 in	 different	 training	
set-ups.	 In	 the	 developed	 countries,	 clinical	 findings	
are losing diagnostic value and more reliance is on 
investigations. However, in a developing country, clinical 
suspicion or diagnosis is still an important approach to 
patient management.
Echocardiogram is the gold standard for accurate 
diagnosis and patients with suspected CHD should be 
referred to a Pediatric Cardiologist for evaluation and 
echocardiography.
DELAYED OR MISSED DIAGNOSIS AND ITS 
CONSEQUENCES
Mortality of neonates diagnosed late with CCHD 
is	 double	 that	 of	 those	 diagnosed	 early	 [4].	 Timely	
diagnosis will help in timely intervention, either catheter 
based or surgical, because major contributors to the 







was	 found	 in	0.14/1000	 live	births	 in	a	study	 from	US.	
Hence,	 they	calculated	 that	30-50%	of	CCHDs	will	 be	
undiagnosed	 on	 discharge	 from	 hospital	 and	 10%	 of	
them	will	die	before	timely	diagnosis	is	made	[13].	This	
diagnostic gap is probably much higher in the developing 
countries. There is paucity of data on this subject from 







done	 between	 18-24	 weeks	 of	 gestation	 [13]	 (ideally	
between	 18-20	weeks),	 provides	 a	 number	 of	 options	
for fetuses diagnosed in utero with mild, moderate or 
severe	 types	 of	 CHD.	 Before	 24	 weeks	 of	 gestation,	
complex CHDs with poor post natal outcome can be 
given the option of discontinuation of the pregnancy. 
Alternatively, plans not to intervene after birth can be 
discussed. Parents are better prepared to handle such 
stressful situations if diagnosed antenatally. 
For CHDs requiring post natal intervention, the 
advantages of antenatal diagnosis is planning delivery 
of the neonate at a center equipped to handle these 
emergencies	 as	 well	 as	 arranging	 finances	 for	 such	
interventions. Timely transferal of the mother before 
delivery will help prompt and management, thereby 
minimizing the morbidity from acidosis, low cardiac 
output, hypoxemia, delayed intubation and ventricular 
dysfunction, which are inevitable complications of 
delayed treatment.
Although	 this	 field	 of	 antenatal	 diagnosis	 continues	
to evolve in Pakistan and many other countries, fetal 
echocardiography	 can	 diagnose	 from	 8-48%	 of	 CHDs	





There is abundant information to support that early 
detection of CHD improves outcome. Early diagnosis 
is ideally made at birth, before hospital discharge, so 
that the family is counseled and management plans are 
discussed. Critical congenital heart disease is a medical 
emergency in newborns, infants as well as children. 
Early diagnosis of non-critical CHDs should be made 
within	the	first	few	weeks	or	months.	Delay	in	diagnosis	
will lead to progress in the natural history of the disease; 
majority of them will either become a high risk for 
surgery or may be deemed inoperable. Therefore, timely 
referral to a center equipped to handle neonates, infants 
and children for appropriate intervention, will reduce 
morbidity and mortality. 
RECOMMENDATIONS
There	 is	a	definite	need	 to	emphasize	on	approach	 to	
early diagnosis of CHD. First, all high risk pregnancies or 
those with risk of CHD should have a fetal echocardiogram 
between	 18-24	 weeks	 of	 gestation,	 ideally	 between	
18-20	 weeks,	 and	 a	 follow	 up	 management	 planned	
in cases of antenatally diagnosed CHDs. Secondly, all 
neonates must have a proper clinical examination before 
discharge (average 3 days after birth) in which cardiac 
murmur and adequacy of lower limb pulses are carefully 
looked for. Pulse oximetry screening, preferably both 
pre and post ductal, should be made mandatory in all 




so that life threatening CCHDs are not missed. Routine 
pulse oximetry and careful examination of pulses, 
abnormal heart sounds and murmur in infants and older 
children should alert heath care providers of underlying 
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